People

Chuck Cleland
Charles M. Cleland, PhD
CDUHR - Co-Director, Transdisciplinary Research Methods Core
NYU Langone Health - Associate Professor, Department of Population Health
Email: Charles.Cleland@nyulangone.org
Education
PhD, Psychology, New School for Social Research
MA, Psychology, New School for Social Research
BA, Psychology, Hampden-Sydney College

Research Interests
HIV prevention, Health disparities, Substance use, Sexual health, Longitudinal data analysis
BIO
Charles Cleland is a quantitative psychologist and biostatistician with more than ten years of experience in the field of public health research. His methodological interests include longitudinal data analysis, meta­-analysis, respondent­ driven sampling, and multilevel modeling. His substantive research interests include health disparities, particularly in the areas of substance use and infectious disease.
Publications

Recent

Brooks MA, Rodwin AH, Gwadz M, Wilton L, Serrano S, Sherpa D, Cleland CM, Munson MR (2026).
Black and Latinx foreign- and US-born young and emerging adults living with HIV: Examining social ecological risk factors and their association with depression, post-traumatic stress Disorder (PTSD), and comorbid depression/PTSD
Journal of Racial and Ethnic Health Disparities, 13 (4), 2812-2826. doi: 10.1007/s40615-025-02458-x. PMCID: PMC12228975.

Ivasiy R, Earnshaw VA, Huh J, Cleland CM, Friedman SR, Schneider JA, Ompad D, Bluthenthal RN, Walters SM (2026).
Development and validation of a provider-specific anticipated stigma scale for people who inject drugs
AIDS and Behavior, 30 (8), 2461-2470. doi: 10.1007/s10461-026-05071-z. PMCID: PMC13486044.

Bunting AM, Griffin B, Rubens A, Lima D, Lam V, Bender M, Fawole A, McNeely J, Cleland CM (2026).
Refining a novel measure of polysubstance use: Applying the cognitive interview method with people who use drugs
Substance Use and Misuse, 61 (11), 1921-1927. doi: 10.1080/10826084.2026.2632181. PMCID: PMC13011491.

Palamar JJ, Krotulski AJ, Abukahok N, Acosta P, Walton SE, Stang B, Cleland CM (2026).
Considering unintentional exposure when testing for cocaine use via oral fluid testing
Forensic Science International, 387, 113052. doi: 10.1016/j.forsciint.2026.113052. PMCID: PMC13307504.

Palamar JJ, Krotulski AJ, Abukahok N, Acosta P, Walton SE, Stang B, Cleland CM (2026).
Differentiating intentional ketamine use from unintentional exposure as an adulterant using oral fluid testing
Journal of Forensic Sciences [Epub 2026 Jun 19]. doi: 10.1111/1556-4029.70391. PMCID: PMC13286244.


Notable

Kurth AE, Spielberg F, Cleland CM, Lambdin B, Bangsberg DR, Frick PA, Severynen AO, Clausen M, Norman RG, Lockhart D, Simoni JM, Holmes KK (2014).
Computerized counseling reduces HIV-1 viral load and sexual transmission risk: Findings from a randomized controlled trial
Journal of Acquired Immune Deficiency Syndromes, 65 (5), 611-620. doi: 10.1097/QAI.0000000000000100. PMCID: PMC3999203.

Marsch LA, Guarino H, Acosta M, Aponte-Melendez Y, Cleland C, Grabinski M, Brady R, Edwards J (2014).
Web-based behavioral treatment for substance use disorders as a partial replacement of standard methadone maintenance treatment
Journal of Substance Abuse Treatment, 46 (1), 43-51. doi: 10.1016/j.jsat.2013.08.012. PMCID: PMC3839618 .

Rosenblum A, Joseph H, Fong, C, Kipnis S, Cleland CM, Portenoy RK (2003).
Prevalence and characteristics of chronic pain among chemically dependent patients in methadone maintenance and residential treatment facilities
Journal of the American Medical Association, 289 (18), 2370-2378. doi: 10.1001/jama.289.18.2370.

Dr. Cleland's Research Gate Profile
Selected Press